Kimryn Rathmell: BICConf24 emphasizes the role of creating sustainable pathways for future black cancer pioneers

Kimryn Rathmell shared on X:

“BICConf24 emphasizes the role we all have in creating sustainable pathways for future black cancer pioneers. A diverse talent pipeline is essential to eliminate inequities and drive advancements in cancer research that benefit everyone.”

Source: Kimryn Rathmell/X

Dr. Kimryn Rathmell is a distinguished leader and researcher in the field of kidney cancer. Specializing in the research and treatment of complex and hereditary kidney cancers. 

She has held leadership positions with organizations such as the American Society of Clinical Oncology and the American Society for Clinical Investigation, she has been elected to esteemed academies including the Association of American Physicians, the American Academy of Arts and Sciences, and the National Academy of Medicine.

Currently serving as the director of the National Cancer Institute, Dr. Rathmell continues to lead research initiatives and advance the understanding and treatment of kidney cancer, ultimately improving the lives of patients worldwide.